NCT07761429
- Conditions
- Cancer of Unknown Primary Site, Neoplasm Metastasis, Neoplasms, +4 more
- Locations
-
- Shanghai tumor hospital Shanghai, Shanghai Municipality, China
Clinical trial condition
Cancer of Unknown Primary Site
Explore clinical trials studying Cancer of Unknown Primary Site. Study availability and eligibility vary by location and protocol.
13 public trials
2 recruiting studies
Cancer of Unknown Primary Site trial results
NCT04504604
- Conditions
- Adenocarcinoma, Cancer of Unknown Primary Site, Carcinoma, +10 more
- Locations
-
- TargetCancer Foundation Cambridge, Massachusetts, United States
Not yet recruiting
18F-FAPI PET in Cancers of Unknown Primary Site
NCT07372963
- Conditions
- Cancer of Unknown Primary Site, Neoplasm Metastasis, Neoplasms, +4 more
- Locations
-
- The First Affiliated Hospital, Zhejiang University School of Medicine Hangzhou, Zhejiang, China
Not yet recruiting
The NorCUP Trial: Improving Prognosis and Personalized Treatment in Cancer of Unknown Primary (CUP)
NCT07366008
- Conditions
- Cancer of Unknown Primary Site, Neoplasm Metastasis, Neoplasms, +4 more
- Locations
-
- Haukeland University Hospital Bergen, Norway
- Akershus University Hospital Oslo, Norway
- Oslo University Hospital Oslo, Norway
- Stavanger University Hospital Stavanger, Norway
Active, not recruiting
Prospective Exploratory Study of FAPi PET/CT With Histopathology Validation in Patients With Various Cancers
NCT04459273
- Conditions
- Adenocarcinoma, Adrenal Gland Diseases, Adrenal Gland Neoplasms, +77 more
- Locations
-
- UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States
NCT03752333
- Conditions
- Cancer of Unknown Primary Site, Carcinoma, Neoplasm Metastasis, +7 more
- Locations
-
- Hammersmith Hospital - Imperial College Healthcare NHS Trust Hammersmith, London, United Kingdom
- Gastrointestinal Units, The Royal Marsden NHS Foundation Trust (Sutton and Chelsea) Sutton, Surrey, United Kingdom
- Guy's Cancer Centre, Guy's and St Thomas' NHS Foundation Trust London, United Kingdom
Completed
Sintilimab in Cancer of Unknown Primary
NCT05024968
- Conditions
- Cancer of Unknown Primary Site, Neoplasm Metastasis, Neoplasms, +4 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT03498521
- Conditions
- Cancer of Unknown Primary Site, Neoplasm Metastasis, Neoplasms, +4 more
- Locations
-
- Blacktown Hospital Blacktown, New South Wales, Australia
- GenesisCare North Shore St Leonards, New South Wales, Australia
- Icon Cancer Foundation South Brisbane, Queensland, Australia
- Lkh-Univ. Klinikum Graz Graz, Austria
NCT04750109
- Conditions
- Cancer of Unknown Primary Site, Neoplasm Metastasis, Neoplasms, +4 more
- Locations
-
- UCL Cancer Institute London, United Kingdom
- Royal United Hospitals Bath NHS Foundation Trust Bath, United Kingdom
- Velindre Cancer Centre Cardiff, United Kingdom
- Edinburgh Cancer Centre Edinburgh, United Kingdom
NCT05841966
- Conditions
- Cancer of Unknown Primary Site, Carcinoma, Carcinoma, Squamous Cell, +11 more
- Locations
-
- Århus University Hospital, Department of Otorhinolaryngology, Head & Neck Surgery Aarhus, Denmark
- Rigshospitalet, Department of Otorhinolaryngology, Head & Neck Surgery & Audiology Copenhagen, Denmark